SEC Form 4 · accession 0000899866-15-000068
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard Bell
Officer — CEO · Director
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 9:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per shareF1 | Feb 27, 2015 | A | 22,300 | $0.00 | A | 966,608 | D | |
| Common Stock, par value $.0001 per shareF2 | Mar 2, 2015 | S | 1,230 | $180.34 | D | 965,378 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF3 | $180.37 | Feb 27, 2015 | A | 98,200 | A | Feb 27, 2016 | Feb 27, 2025 | Common Stock, par value $.0001 per share | 98,200 | 98,200 | D |
Explanation of responses
- F1Award of Restricted Stock Units under the 2004 Incentive Plan. 25% vests on each anniversary of the grant date.
- F2This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- F325% vests on the first anniversary of the grant date and 1/16 every three months thereafter.